This Editorial article provides an insight into how pharmacogenomics can assist in guided dosing of fentanyl for the treatment of pain.
This review evaluates techniques and applications of MRI for evaluating white matter injury in mild traumatic brain injury, including an overview of current literature and future perspectives.
In this review, the authors discuss the history of DBS for Parkinson’s disease, as well as outcomes, recent advances, and where the field will go next.
The Systemic Synuclein Sampling Study (S4) is uniquely designed to identify a reproducible diagnostic and progression biomarker for Parkinson’s disease.
In this Editorial, researchers from McGovern Medical School put the recent Lennox et al. Lancet paper in context, looking at the role of neuronal cell surface antibodies in schizophrenia.
The aim of this editorial from the journal Pain Management is to analyze the current status of evidence for TENS for pain relief.
Creatine supplementation has not been researched in mTBI, but shows some potential as a neuroprotective when administered prior to or after TBI.
This research article presents the first-in-man data demonstrating a relationship between changes in cognition and β2M. The phenomenon was reversible, which indicates its therapeutic potential.
This article examines a number of different disease-modifying therapy strategies for the treatment of relapsing-remitting multiple sclerosis.
This review provides a comprehensive overview of miRNAs as biomarkers and therapeutic targets for neurodegenerative disorders.